OPN1MW and schizophrenia: In patients diagnosed with either schizophrenia or a related psychotic disorder within five years and dosed with a stable antipsychotic agent for one month prior to study inclusion, adjunctive CBD therapy (600 mg/day) for twenty-eight days improved functional connectivity in the Default Mode Network (DMN) of the brain (76).